Development of a Novel Ectonucleotidase Assay Suitable for High-Throughput Screening

被引:15
作者
Sachsenmeier, Kris F. [1 ]
Hay, Carl [1 ]
Brand, Erin [1 ]
Clarke, Lori [1 ]
Rosenthal, Kim [1 ]
Guillard, Sandrine [2 ]
Rust, Steven [2 ]
Minter, Ralph [2 ]
Hollingsworth, Robert [1 ]
机构
[1] Medimmune LLC, Gaithersburg, MD 20878 USA
[2] MedImmune, Cambridge, England
关键词
enzyme assay; ectonucleotidase; luciferase; antibody; antagonist;
D O I
10.1177/1087057112443987
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
5'-Ectonucleotidase (NT5E) catalyzes the conversion of adenosine monophosphate to adenosine and free phosphate. The role of this ectonucleotidase and its production of adenosine are linked with immune function, angiogenesis, and cancer. NT5E activity is typically assayed either by chromatographic quantification of substrates and products using high-performance liquid chromatography (HPLC) or by quantification of free phosphate using malachite green. These methods are not suitable for robust screening assays of NT5E activity. HPLC is not readily suitable for the rapid and efficient assay of multiple samples and malachite green is highly sensitive to the phosphate-containing buffers common in various media and sample buffers. Here the development and validation of a novel high-throughput ectonucleotidase screening assay are described, which makes use of a luciferase-based assay reagent, the Promega CellTiter-Glo kit, to measure the catabolism of AMP by NT5E. This multiwell plate-based assay facilitates the screening of potential ectonucleotidase antagonists and is unaffected by the presence of contaminating phosphate molecules present in screening samples.
引用
收藏
页码:993 / 998
页数:6
相关论文
共 7 条
[1]   METABOLISM OF ADENINE-NUCLEOTIDES BY ECTO-ENZYMES OF VASCULAR ENDOTHELIAL AND SMOOTH-MUSCLE CELLS IN CULTURE [J].
PEARSON, JD ;
CARLETON, JS ;
GORDON, JL .
BIOCHEMICAL JOURNAL, 1980, 190 (02) :421-429
[2]   Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase [J].
Pellegatti, Patrizia ;
Raffaghello, Lizzia ;
Bianchi, Giovanna ;
Piccardi, Federica ;
Pistoia, Vito ;
Di Virgilio, Francesco .
PLOS ONE, 2008, 3 (07)
[3]   CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis [J].
Stagg, John ;
Divisekera, Upulie ;
Duret, Helene ;
Sparwasser, Tim ;
Teng, Michele W. L. ;
Darcy, Phillip K. ;
Smyth, Mark J. .
CANCER RESEARCH, 2011, 71 (08) :2892-2900
[4]   Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis [J].
Stagg, John ;
Divisekera, Upulie ;
McLaughlin, Nicole ;
Sharkey, Janelle ;
Pommey, Sandra ;
Denoyer, Delphine ;
Dwyer, Karen M. ;
Smyth, Mark J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (04) :1547-1552
[5]   Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library [J].
Vaughan, TJ ;
Williams, AJ ;
Pritchard, K ;
Osbourn, JK ;
Pope, AR ;
Earnshaw, JC ;
McCafferty, J ;
Hodits, RA ;
Wilton, J ;
Johnson, KS .
NATURE BIOTECHNOLOGY, 1996, 14 (03) :309-314
[6]   CD73: A Novel Target for Cancer Immunotherapy [J].
Zhang, Bin .
CANCER RESEARCH, 2010, 70 (16) :6407-6411
[7]   A simple statistical parameter for use in evaluation and validation of high throughput screening assays [J].
Zhang, JH ;
Chung, TDY ;
Oldenburg, KR .
JOURNAL OF BIOMOLECULAR SCREENING, 1999, 4 (02) :67-73